Related Experiment Video
Updated: Jul 18, 2026
06:51
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Oral contraceptives and vascular disease
P D Stolley1, B L Strom, P E Sartwell
1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
Epidemiologic Reviews
|January 1, 1989
Summary
Cardiovascular risks associated with oral contraceptives persist, with newer formulations showing minimal risk reduction. Physicians should still advise caution, especially for women over 35 and smokers.
Area of Science:
- Cardiovascular Health
- Reproductive Medicine
Background:
- Oral contraceptives (OCs) are widely used for birth control.
- Previous reviews highlighted cardiovascular risks associated with OCs.
- Ongoing research aims to clarify risks with evolving formulations.
Purpose of the Study:
- To update the understanding of cardiovascular risks associated with oral contraceptives.
- To assess if newer formulations have altered the risk profile.
- To provide current guidance for healthcare providers.
Main Methods:
- Review of existing studies on oral contraceptive use and cardiovascular events.
- Analysis of available data, acknowledging limitations in formulation-specific information.
- Interpretation of findings in the context of previous research.
Main Results:
- Current data offer limited new insights beyond the 1982 review.
- Newer oral contraceptive formulations may present a small to modest reduction in risk.
- Statistical power often insufficient to analyze risks by specific formulations.
Conclusions:
- Cardiovascular risks associated with oral contraceptives remain a concern.
- Physician guidance includes avoiding OCs in women over 35 and smokers.
- Lowest effective estrogen dose and monitoring for hypertension are recommended.
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...